
Genomed Pharmaceuticals Private Limited
About Genomed Pharmaceuticals Private Limited
Data last updated:
Genomed Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 27 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC264048. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abdullah (Managing Director) and Faiz Mauhammad.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at E – 81/B Khasra No – 61 Gali No – 12 Shastri Park, Delhi, India – 110053.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.46 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹9,559 (net margin -6.6%) and EBITDA of -₹9,559 (EBITDA margin -6.6%). Revenue has declined at a compounded annual rate (CAGR) of 106% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Genomed Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 81/B Khasra No – 61 Gali No – 12 Shastri Park, Delhi, India – 110053
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Genomed Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Genomed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Genomed Pharmaceuticals Private Limited, buy the company report.
Financials of Genomed Pharmaceuticals Private Limited
FY 2020 filings availableGenomed Pharmaceuticals Private Limited reported revenue of ₹1.46 Lakh (down 7% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 7% fall in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9,559 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9,559 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.6% | ||||
| Net Profit Margin | -6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genomed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genomed Pharmaceuticals Private Limited
Genomed Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Faiz Mauhammad | Director | 27 Jan 2014 | 12 Years 9 Months | Current |
| Abdullah | Managing Director | 27 Jan 2014 | 12 Years 9 Months | Current |
Auditor
Genomed Pharmaceuticals Private Limited is audited by SCM ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SCM ASSOCIATES | FY 2017 | 314173E |
Shareholding
The shareholding of Genomed Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Genomed Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genomed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genomed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Genomed Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Genomed Pharmaceuticals Private Limited, buy the company report.
Recent activity
Genomed Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Abdullah was appointed as Managing Director on 27 Jan 2014.
Frequently asked questions
Genomed Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 27 January 2014 (12+ years old) and is registered under CIN U24100DL2014PTC264048.
Genomed Pharmaceuticals has 2 current directors:
- Abdullah - Managing Director
- Faiz Mauhammad - Director
The latest financial statements of Genomed Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
No. Genomed Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Genomed Pharmaceuticals is U24100DL2014PTC264048. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genomed Pharmaceuticals was incorporated on 27 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Abdullah was appointed as Managing Director on 27 Jan 2014. Faiz Mauhammad was appointed as Director on 27 Jan 2014.
The registered office of Genomed Pharmaceuticals is at E – 81B Khasra No – 61 Gali No – 12 Shastri Park, Delhi, India – 110053.
Genomed Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Genomed Pharmaceuticals is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.

